43 related articles for article (PubMed ID: 32648963)
1.
Niemeyer CM; Erlacher M
Haematologica; 2024 Apr; ():. PubMed ID: 38618667
[TBL] [Abstract][Full Text] [Related]
2. Refining risk stratification to improve prognosis in juvenile myelomonocytic leukemia.
Nunn JL; Fraser CJ
Haematologica; 2024 May; ():. PubMed ID: 38813703
[TBL] [Abstract][Full Text] [Related]
3. International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia.
Schönung M; Meyer J; Nöllke P; Olshen AB; Hartmann M; Murakami N; Wakamatsu M; Okuno Y; Plass C; Loh ML; Niemeyer CM; Muramatsu H; Flotho C; Stieglitz E; Lipka DB
Clin Cancer Res; 2021 Jan; 27(1):158-168. PubMed ID: 33139265
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of Gene Mutation and Clinical Characteristics in 19 Children with Juvenile Myelomonocytic Leukemia].
Weng KZ; Zheng YZ; Zhuang SQ; Chen HY; LE SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1811-1818. PubMed ID: 33283703
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen disparities reduce relapse after hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A single-center retrospective study from China.
Lin YC; Luo CJ; Miao Y; Wang JM; Luo CY; Qin X; Cai JY; Li BS; Chen J
Pediatr Transplant; 2021 Mar; 25(2):e13825. PubMed ID: 33131184
[TBL] [Abstract][Full Text] [Related]
6. Role of lncRNA Morrbid in PTPN11(Shp2)E76K-driven juvenile myelomonocytic leukemia.
Cai Z; Zhang C; Kotzin JJ; Williams A; Henao-Mejia J; Kapur R
Blood Adv; 2020 Jul; 4(14):3246-3251. PubMed ID: 32697817
[TBL] [Abstract][Full Text] [Related]
7. Distinctive phenotypes in two children with novel germline
Bagla S; Regling KA; Wakeling EN; Gadgeel M; Buck S; Zaidi AU; Flore LA; Chicka M; Schiffer CA; Chitlur MB; Ravindranath Y
Pediatr Hematol Oncol; 2021 Feb; 38(1):65-79. PubMed ID: 32990483
[No Abstract] [Full Text] [Related]
8. Immunophenotypic characteristics of juvenile myelomonocytic leukaemia and their relation with the molecular subgroups of the disease.
Frisanco Oliveira A; Tansini A; Toledo TR; Balceiro R; Onofre Vidal D; de Martino Lee ML; Lorand-Metze I; Lopes LF
Br J Haematol; 2021 Jan; 192(1):129-136. PubMed ID: 32966606
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia.
Louka E; Povinelli B; Rodriguez-Meira A; Buck G; Wen WX; Wang G; Sousos N; Ashley N; Hamblin A; Booth CAG; Roy A; Elliott N; Iskander D; de la Fuente J; Fordham N; O'Byrne S; Inglott S; Norfo R; Salio M; Thongjuea S; Rao A; Roberts I; Mead AJ
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33416891
[TBL] [Abstract][Full Text] [Related]
10. Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.
Wintering A; Dvorak CC; Stieglitz E; Loh ML
Blood Adv; 2021 Nov; 5(22):4783-4793. PubMed ID: 34525182
[TBL] [Abstract][Full Text] [Related]
11. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
12. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
13. [Juvenile myelomonocytic leukemias].
Lachenaud J; Strullu M; Baruchel A; Cavé H
Bull Cancer; 2014 Mar; 101(3):302-13. PubMed ID: 24691193
[TBL] [Abstract][Full Text] [Related]
14. Juvenile myelomonocytic leukemia.
Proytcheva M
Semin Diagn Pathol; 2011 Nov; 28(4):298-303. PubMed ID: 22195407
[TBL] [Abstract][Full Text] [Related]
15. CD14/16 monocyte profiling in juvenile myelomonocytic leukemia.
Gadgeel M; Bagla S; Buck S; Shamoun M; Ravindranath Y
Pediatr Blood Cancer; 2020 Sep; 67(9):e28555. PubMed ID: 32648963
[TBL] [Abstract][Full Text] [Related]
16. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
Xiang Y; Liang B; Zhang X; Zheng F
Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
